Skip to content
★ Sign in to follow
Ovation Science Inc. logo

Ovation Science Inc. Stock: price and insider trades · Canada

Ovation Science Inc.: what insiders have been doing

Ovation Science Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. Between 22 October 2025 and 22 October 2026, 1 insider published 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Over the last twelve months, not one insider purchase of Ovation Science Inc. stock was filed.

Across the 2,470 companies tracked on its exchange, the median is 12 filings; at 2 filings, this issuer sits below that mark. Over the whole record (from 2018), the tally stands at 13 purchases and 8 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Vivos Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.

Insider Decl.
25
Thresholds
n/a
Buy Volume
€21,650
13 ops. · all time
Sell Volume
€35,750
8 ops. · all time

Who traded when

BuySale
Joan Chypyha1 sale
Shane Dungey1 buy

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

CA$0.03
Analyst consensus
·
Income statement
RevenueCA$67.9k
Gross profitCA$58.1k86% margin
EBITDA-CA$580.9k-856% margin
Net income-CA$631.3k-929.9% margin
Valuation
Beta0.58
Balance sheet & cash
Total debtCA$283.1k
Free Cash Flow-CA$76.4k
Profitability & ownership
ROA-1210.2%
% insiders23.4%
% institutions0.0%
Last declaration on 9 September 2026
Declarations25 total
  • ●
    4 - Director of IssuerExecutives
    0SEDI
    WarrantsTSXSEDI:4775499
  • ●
    4 - Director of IssuerExecutives
    10,000 CAD13SEDI
    200,000 shares@ CA$0.0518.7% of flowCommon SharesTSXSEDI:4775498
  • ▼
    4 - Director of IssuerExecutives
    3,000 CAD19SEDI
    100,000 shares@ CA$0.03100.0% of flowCommon SharesTSXSEDI:4493050
  • ●
    4 - Director of IssuerExecutives
    0SEDI
    Common SharesTSXSEDI:4444225
  • ▲
    4 - Director of IssuerExecutives
    2,500 CAD19SEDI
    100,000 shares@ CA$0.025100.0% of flowCommon SharesTSXSEDI:4444226
    Canonical exit: 30 Mar 2025 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    4,118 CAD19SEDI
    30,500 shares@ CA$0.135100.0% of flowCommon SharesTSXSEDI:3795550
    Canonical exit: 25 Nov 2021 (T+90)
  • ▼
    4 - Director of IssuerExecutives
    26,500 CAD16SEDI
    50,000 shares@ CA$0.5352.8% of flowCommon SharesTSXSEDI:3578662
  • ▼
    4 - Director of IssuerExecutives
    5,265 CAD12SEDI
    10,000 shares@ CA$0.526510.6% of flowCommon SharesTSXSEDI:3568037
  • ▼
    4 - Director of IssuerExecutives
    3,542 CAD12SEDI
    8,000 shares@ CA$0.44287.1% of flowCommon SharesTSXSEDI:3540900
  • ▼
    4 - Director of IssuerExecutives
    1,080 CAD11SEDI
    2,000 shares@ CA$0.542.1% of flowCommon SharesTSXSEDI:3540903
  • ▼
    4 - Director of IssuerExecutives
    4,400 CAD12SEDI
    10,000 shares@ CA$0.448.8% of flowCommon SharesTSXSEDI:3540901
  • ▼
    4 - Director of IssuerExecutives
    4,950 CAD18SEDI
    11,000 shares@ CA$0.4513.3% of flowCommon SharesTSXSEDI:3538817
  • ▲
    4 - Director of IssuerExecutives
    2,024 CAD18SEDI
    4,600 shares@ CA$0.445.4% of flowCommon SharesTSXSEDI:3538818
    Canonical exit: 8 Jul 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    2,816 CAD18SEDI
    6,400 shares@ CA$0.447.5% of flowCommon SharesTSXSEDI:3538819
    Canonical exit: 8 Jul 2020 (T+90)
  • ◇
    4 - Director of IssuerExecutives
    0SEDI
    50,000 sharesCommon SharesTSXSEDI:3536303
  • ▼
    4 - Director of IssuerExecutives
    5,700 CAD19SEDI
    15,000 shares@ CA$0.3822.0% of flowCommon SharesTSXSEDI:3499821
  • ▲
    4 - Director of IssuerExecutives
    10,115 CAD21SEDI
    59,500 shares@ CA$0.1738.6% of flowCommon SharesTSXSEDI:3490154
    Canonical exit: 29 Apr 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    950 CAD18SEDI
    5,000 shares@ CA$0.199.1% of flowCommon SharesTSXSEDI:3455060
    Canonical exit: 19 Feb 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    975 CAD18SEDI
    5,000 shares@ CA$0.1959.3% of flowCommon SharesTSXSEDI:3455058
    Canonical exit: 19 Feb 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    2,950 CAD20SEDI
    10,000 shares@ CA$0.29528.8% of flowCommon SharesTSXSEDI:3431631
    Canonical exit: 29 Dec 2019 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    630 CAD18SEDI
    2,000 shares@ CA$0.3156.0% of flowCommon SharesTSXSEDI:3412459
    Canonical exit: 13 Nov 2019 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    2,560 CAD19SEDI
    8,000 shares@ CA$0.3224.3% of flowCommon SharesTSXSEDI:3412456
    Canonical exit: 13 Nov 2019 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    750 CAD16SEDI
    3,000 shares@ CA$0.257.1% of flowCommon SharesTSXSEDI:3409335
    Canonical exit: 10 Nov 2019 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    1,500 CAD12SEDI
    5,000 shares@ CA$0.3014.1% of flowCommon SharesTSXSEDI:3270901
    Canonical exit: 26 Feb 2019 (T+90)
  • ▲
    4 - Director of IssuerExecutives
    145 CAD11SEDI
    500 shares@ CA$0.291.4% of flowCommon SharesTSXSEDI:3270902
    Canonical exit: 26 Feb 2019 (T+90)

25 of 25 declarations

About Ovation Science Inc.

Ovation Science Inc. is a company focused on developing pharmaceutical and cosmetic products based on cannabinoids. It is listed on the Toronto Stock Exchange (XTSE).